These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7390932)

  • 21. 3'-deoxy-3'-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography.
    Barthel H; Cleij MC; Collingridge DR; Hutchinson OC; Osman S; He Q; Luthra SK; Brady F; Price PM; Aboagye EO
    Cancer Res; 2003 Jul; 63(13):3791-8. PubMed ID: 12839975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnosis of malignant neoplasm with 201Tl chloride (author's transl)].
    Yano K; Morita S; Furukawa Y; Umezaki N; Koga H; Koono A; Ozaki M; Ootake H
    Kaku Igaku; 1978 Oct; 15(7):989-97. PubMed ID: 739681
    [No Abstract]   [Full Text] [Related]  

  • 23. Potential organ- or tumor-imaging agents. 21. Acyl-labeled esters of cholesterol.
    Counsell RE; Seevers RH; Korn N; Schwendner SW
    J Med Chem; 1981 Jan; 24(1):5-6. PubMed ID: 7205875
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacokinetic analysis of 5-[18F]fluorouracil tissue concentrations measured with positron emission tomography in patients with liver metastases from colorectal adenocarcinoma.
    Kissel J; Brix G; Bellemann ME; Strauss LG; Dimitrakopoulou-Strauss A; Port R; Haberkorn U; Lorenz WJ
    Cancer Res; 1997 Aug; 57(16):3415-23. PubMed ID: 9270007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of skeletal metastases: a comparison of three radioisotopic techniques using 18F and radiology.
    Merrick MV
    Br J Radiol; 1973 Nov; 46(551):968-71. PubMed ID: 4761141
    [No Abstract]   [Full Text] [Related]  

  • 26. 18 F recoil labeling.
    Lebowitz E; Richards P; Baranosky J
    Int J Appl Radiat Isot; 1972 Aug; 23(8):392-4. PubMed ID: 5080822
    [No Abstract]   [Full Text] [Related]  

  • 27. Radionuclide imaging in pharmaceutical, physiological and pharmacological research.
    Hardy JG; Wilson CG
    Clin Phys Physiol Meas; 1981 May; 2(2):71-121. PubMed ID: 6802552
    [No Abstract]   [Full Text] [Related]  

  • 28. [Radionuclide-labelled liposomes for demonstrating malignant neoplasms].
    Kostenikov NA; Fadeev NP; Rozenberg OA
    Med Radiol (Mosk); 1990 Nov; 35(11):44-7. PubMed ID: 2259284
    [No Abstract]   [Full Text] [Related]  

  • 29. No-carrier-added fluorine-18-labeled N-methylspiroperidol: synthesis and biodistribution in mice.
    Shiue CY; Fowler JS; Wolf AP; McPherson DW; Arnett CD; Zecca L
    J Nucl Med; 1986 Feb; 27(2):226-34. PubMed ID: 3712039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluorine-18 patents (2009-2015). Part 1: novel radiotracers.
    Brooks AF; Drake LR; Stewart MN; Cary BP; Jackson IM; Mallette D; Mossine AV; Scott PJ
    Pharm Pat Anal; 2016; 5(1):17-47. PubMed ID: 26670619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 18F and 85Sr scintimetry in the study of primary arthropathies.
    Muheim G; Crutchlow WP
    Br J Radiol; 1971 Apr; 44(520):290-4. PubMed ID: 5552149
    [No Abstract]   [Full Text] [Related]  

  • 32. The chemical form of cyclotron-produced 18F used in bone scintigraphy.
    Chaudhri MA; Gartside JM; Ranicar A
    Br J Radiol; 1970 Aug; 43(512):534-6. PubMed ID: 5433363
    [No Abstract]   [Full Text] [Related]  

  • 33. Fluorine-18-labeled benzamide analogues for imaging the sigma2 receptor status of solid tumors with positron emission tomography.
    Tu Z; Xu J; Jones LA; Li S; Dumstorff C; Vangveravong S; Chen DL; Wheeler KT; Welch MJ; Mach RH
    J Med Chem; 2007 Jul; 50(14):3194-204. PubMed ID: 17579383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Bone scanning with 18F].
    Kawana M
    Rinsho Hoshasen; 1975 Oct; 20(11):1003-4. PubMed ID: 1238687
    [No Abstract]   [Full Text] [Related]  

  • 35. [Positron emitters for the study of tumor metabolism].
    Strauss LG
    Radiologe; 1989 Jul; 29(7):318-21. PubMed ID: 2667030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumour localization.
    McCready VR
    Br Med Bull; 1980 Sep; 36(3):209-13. PubMed ID: 7020847
    [No Abstract]   [Full Text] [Related]  

  • 37. Whole-body positron emission tomography: normal variations, pitfalls, and technical considerations.
    Gordon BA; Flanagan FL; Dehdashti F
    AJR Am J Roentgenol; 1997 Dec; 169(6):1675-80. PubMed ID: 9393189
    [No Abstract]   [Full Text] [Related]  

  • 38. The clinical use of fluorine18 in bone scanning.
    Gastesi RA; Vulpetti AT; Kosnik TL; Tucker WG; Talley RW
    Henry Ford Hosp Med J; 1969; 17(2):107-16. PubMed ID: 5783813
    [No Abstract]   [Full Text] [Related]  

  • 39. [Examination of the kinetics of 167thulium with respect to its tumour affinity (author's transl)].
    Franke WG; Hennig K; Beyer GJ; Henke E; Khalkin VA
    Radiobiol Radiother (Berl); 1979 Jun; 20(3):412-9. PubMed ID: 515402
    [No Abstract]   [Full Text] [Related]  

  • 40. [The clinical evaluation of whole body scanning with 87m Sr and 18 F for detecting bone tumors].
    Saegusa T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1972 Apr; 32(1):21-49. PubMed ID: 4506021
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.